Venture Life Group (VLG)

Sector:

Health Care

Index:

FTSE AIM All-Share

40.25p
   
  • Change Today:
    -0.25p
  • 52 Week High: 42.25
  • 52 Week Low: 27.50
  • Currency: UK Pounds
  • Shares Issued: 126.50m
  • Volume: 0
  • Market Cap: £50.92m

UltraDEX continues to drive growth at Venture Life

By Josh White

Date: Wednesday 12 Jul 2017

LONDON (ShareCast) - (ShareCast News) - Consumer self-care company Venture Life Group reported unaudited half-year revenue growth of 28% on Wednesday, in a trading update for the six months to June, with revenues totalling £7.8m.
The AIM-traded firm said that on a like for like basis, including a full six months of Periproducts revenues for the first half of 2016, that was growth of 18% over the same time last year.

Periproducts - sold under the brand name UltraDEX UK - recorded its highest month of revenue in June for at least the last five years, Venture Life's board said.

It also reported a record month in Biokosmes as it recorded its largest ever revenue for a single month in June.

A total of four new deals were signed internationally during the period, including one on UltraDEX.

"The first half of 2017 has shown continued growth and momentum in the business," said chief executive Jerry Randall.

"The UltraDEX acquisition is now fully integrated and delivering the synergies and profitability expected.

"It is also attracting good interest internationally ... [validating] our decision to make the acquisition and also proves the model we have for utilising the good operational leverage that we have which is available for future acquisitions."

The board reported that June saw the second UltraDEX promotional campaign in the year so far in the UK, which included television advertising and promotions through independent coffee shops, among other activities.

July would also see the launch of the newly-refreshed range of packaging in the company's major pharmacy partner, along with the launch of the UltraDEX sensitive range and new one litre pack sizes.

Venture Life's board said there was also confirmation in the first half of the year that store penetration would increase from July, with 1,503 new listings of UltraDEX in stores across the UK with the firm's major pharmacy partner.

"I am delighted with the continued organic growth of the business in challenging markets and in particular, that we have delivered a record level of sales during June in both Biokosmes, and UltraDEX," Randall added.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

VLG Market Data

Currency UK Pounds
Share Price 40.25p
Change Today -0.25p
% Change -0.62 %
52 Week High 42.25
52 Week Low 27.50
Volume 0
Shares Issued 126.50m
Market Cap £50.92m

VLG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.27% above the market average93.27% above the market average93.27% above the market average93.27% above the market average93.27% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
57.57% above the market average57.57% above the market average57.57% above the market average57.57% above the market average57.57% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Income Not Available
Growth
19.83% above the market average19.83% above the market average19.83% above the market average19.83% above the market average19.83% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

VLG Dividends

  Latest Previous
  Final Interim
Ex-Div 24-May-18 n/a
Paid 22-Jun-18 n/a
Amount 0.040p 0.000p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

VLG Key Personnel

CEO Jerry Randall
CFO Daniel Wells

Top of Page